Optimind Pharma Corp. (CSE:OMND)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
-0.0050 (-50.00%)
Jun 30, 2025, 9:30 AM EDT

Optimind Pharma Income Statement

Millions CAD. Fiscal year is Mar - Feb.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Feb '25 Feb '24 Feb '23 Feb '22
0.120.120.170.1
Revenue Growth (YoY)
-3.73%-27.72%70.64%-
Cost of Revenue
0.050.060.120.04
Gross Profit
0.070.060.050.06
Selling, General & Admin
0.270.510.920.44
Research & Development
-0.12--
Operating Expenses
0.270.810.960.47
Operating Income
-0.2-0.75-0.91-0.4
Interest Expense
--0.09-0.07-0.02
Other Non Operating Income (Expenses)
-0.01-0.21-0.03-
EBT Excluding Unusual Items
-0.22-1.05-1.01-0.42
Impairment of Goodwill
---0.86-
Gain (Loss) on Sale of Investments
---0.31-
Asset Writedown
--0.37-0.65-
Other Unusual Items
-0.02-0.26-
Pretax Income
-0.22-1.41-3.09-0.42
Income Tax Expense
--0.01-0.01-0.14
Net Income
-0.22-1.4-3.08-0.28
Net Income to Common
-0.22-1.4-3.08-0.28
Shares Outstanding (Basic)
1111008244
Shares Outstanding (Diluted)
1111008244
Shares Change (YoY)
12.00%21.38%88.09%-
EPS (Basic)
-0.00-0.01-0.04-0.01
EPS (Diluted)
-0.00-0.01-0.04-0.01
Gross Margin
58.27%47.63%30.49%63.89%
Operating Margin
-170.38%-612.59%-533.41%-405.39%
Profit Margin
-182.32%-1136.63%-1809.57%-278.57%
EBITDA
--0.74-0.89-0.39
D&A For EBITDA
-0.010.010.01
EBIT
-0.2-0.75-0.91-0.4
EBIT Margin
-170.38%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.